Ratings by SVB Leerink (Andrew Berens)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/21/2021 Mirati Therapeutics MRTX Maintain Outperform
(N/A)
 
 
  Details
9/20/2021 Tango Therapeutics Inc. TNGX New Coverage Outperform
(N/A)
17.30
(15.05)
-13.01% Details
7/29/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
7/20/2021 Elevation Oncology ELEV New Coverage Outperform
(N/A)
12.10
(8.02)
-33.72% Details
6/17/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
6/14/2021 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
6/11/2021 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 Epizyme EPZM Upgrade Outperform
(Underperform)
6.81
(5.35)
-21.44% Details
4/14/2021 Global Blood Therapeutics GBT New Coverage Outperform
(N/A)
40.18
(26.38)
-34.35% Details
3/16/2021 Merus N.V. MRUS New Coverage Outperform
(N/A)
22.04
(22.80)
3.45% Details
3/11/2021 AVEO Pharmaceuticals AVEO Maintain Outperform
(N/A)
 
 
  Details
3/1/2021 Agios Pharma AGIO Downgrade Market Perform
(Outperform)
47.44
(46.49)
-2% Details
2/26/2021 Agios Pharma AGIO Downgrade Market Perform
(Outperform)
50.29
(47.44)
-5.67% Details
2/25/2021 Zymeworks ZYME Downgrade Market Perform
(Outperform)
40.30
(29.87)
-25.88% Details
2/10/2021 Deciphera DCPH Upgrade Outperform
(Market Perform)
48.32
(32.33)
-33.09% Details
2/2/2021 Cullinan Management CGEM New Coverage Outperform
(N/A)
33.77
(22.41)
-33.64% Details
12/28/2020 Kinnate Biopharma KNTE New Coverage Outperform
(N/A)
38.00
(22.85)
-39.87% Details
12/22/2020 Agios Pharma AGIO Maintain Outperform
(N/A)
 
 
  Details
12/17/2020 Cogent COGT New Coverage Outperform
(N/A)
10.53
(8.85)
-15.95% Details
12/8/2020 Forma Therapeutics FMTX Maintain Outperform
(N/A)
 
 
  Details
12/7/2020 HOOKIPA Pharma Inc. HOOK Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Epizyme EPZM Maintain Market Perform
(N/A)
 
 
  Details
9/22/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/14/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
8/13/2020 AVEO Pharmaceuticals AVEO New Coverage Outperform
(N/A)
4.40
(6.90)
56.82% Details
8/7/2020 Puma Biotechnology PBYI Maintain Market Perform
(N/A)
 
 
  Details
7/28/2020 Zentalis Pharmaceuticals ZNTL Maintain Outperform
(N/A)
 
 
  Details
7/14/2020 Forma Therapeutics FMTX New Coverage Outperform
(N/A)
38.53
(23.48)
-39.06% Details
6/1/2020 AstraZeneca AZN Maintain Outperform
(N/A)
 
 
  Details
4/29/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
4/29/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
4/28/2020 Zentalis Pharmaceuticals ZNTL New Coverage Outperform
(N/A)
31.76
(63.23)
99.09% Details
4/27/2020 Clovis Oncology CLVS Downgrade Underperform
(Market Perform)
9.03
(4.46)
-50.61% Details
3/10/2020 Deciphera DCPH Maintain Market Perform
(N/A)
 
 
  Details
3/4/2020 BeiGene, Ltd. BGNE Maintain Outperform
(N/A)
 
 
  Details
2/7/2020 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
1/27/2020 AstraZeneca AZN Maintain Outperform
(N/A)
 
 
  Details
1/24/2020 Epizyme EPZM Downgrade Market Perform
(Outperform)
26.72
(5.35)
-79.98% Details
1/16/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
10/29/2019 Deciphera DCPH Upgrade Market Perform
(Underperform)
39.07
(32.33)
-17.25% Details
9/30/2019 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
9/24/2019 Clovis Oncology CLVS Downgrade Market Perform
(Outperform)
4.59
(4.46)
-2.83% Details
7/31/2019 Incyte INCY Maintain Market Perform
(N/A)
 
 
  Details
7/31/2019 Mirati Therapeutics MRTX Maintain Outperform
(N/A)
 
 
  Details
5/13/2019 HOOKIPA Pharma Inc. HOOK New Coverage Outperform
(N/A)
13.84
(6.59)
-52.38% Details
2/15/2019 Agios Pharma AGIO Upgrade Outperform
(Market Perform)
54.03
(46.49)
-13.96% Details
1/8/2019 Loxo Oncology LOXO Downgrade Market Perform
(Outperform)
139.87
(234.80)
67.87% Details
1/7/2019 Epizyme EPZM Upgrade Outperform
(Market Perform)
5.98
(26.72)
346.82% Details
12/4/2018 Clovis Oncology CLVS Upgrade Outperform
(Market Perform)
19.08
(4.59)
-75.94% Details
12/4/2018 Tesaro TSRO Downgrade Market Perform
(Outperform)
46.38
(74.96)
61.62% Details
10/1/2018 Seattle Genetics SGEN Maintain Outperform
(N/A)
 
 
  Details
9/25/2018 Incyte INCY New Coverage Market Perform
(N/A)
66.59
(69.42)
4.25% Details
9/25/2018 Clovis Oncology CLVS New Coverage Market Perform
(N/A)
32.38
(19.08)
-41.07% Details
9/25/2018 Agios Pharma AGIO New Coverage Market Perform
(N/A)
73.56
(54.03)
-26.55% Details
9/25/2018 Tesaro TSRO New Coverage Outperform
(N/A)
37.69
(46.38)
23.06% Details
9/25/2018 Seattle Genetics SGEN New Coverage Outperform
(N/A)
77.76
(166.67)
114.34% Details
9/25/2018 Loxo Oncology LOXO New Coverage Outperform
(N/A)
159.27
(139.87)
-12.18% Details
9/25/2018 Deciphera DCPH New Coverage Underperform
(N/A)
38.97
(39.07)
0.26% Details
9/25/2018 Blueprint Medicines BPMC New Coverage Outperform
(N/A)
69.61
(108.12)
55.32% Details
9/25/2018 BeiGene, Ltd. BGNE New Coverage Outperform
(N/A)
163.97
(385.03)
134.82% Details